247 related articles for article (PubMed ID: 29734196)
21. miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
Yan HL; Li L; Li SJ; Zhang HS; Xu W
J Biochem Mol Toxicol; 2016 Dec; 30(12):602-607. PubMed ID: 27501413
[TBL] [Abstract][Full Text] [Related]
22. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
23. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
[TBL] [Abstract][Full Text] [Related]
25. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.
Wang S; Mo Y; Midorikawa K; Zhang Z; Huang G; Ma N; Zhao W; Hiraku Y; Oikawa S; Murata M
Oncotarget; 2015 Nov; 6(34):35893-907. PubMed ID: 26486082
[TBL] [Abstract][Full Text] [Related]
26. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
27. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
[TBL] [Abstract][Full Text] [Related]
29. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
Wu SH; Han L; Lu BC; Wang HY; Zheng CP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-204 facilitates the progression of nasopharyngeal carcinoma by targeting CXCR4 through NF-κB signaling pathway.
Zong G; Han J; Yue Z; Liu Y; Cui Z; Shi L
J BUON; 2020; 25(2):1098-1104. PubMed ID: 32521912
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-κB.
Shi Z; Hu Z; Chen D; Huang J; Fan J; Zhou S; Wang X; Hu J; Huang F
Mol Med Rep; 2016 Feb; 13(2):1732-8. PubMed ID: 26718506
[TBL] [Abstract][Full Text] [Related]
32. Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells.
Miao BP; Zhang RS; Li M; Fu YT; Zhao M; Liu ZG; Yang PC
Cell Mol Immunol; 2015 Nov; 12(6):750-6. PubMed ID: 25544502
[TBL] [Abstract][Full Text] [Related]
33. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200c promotes tumor cell proliferation and migration by directly targeting dachshund family transcription factor 1 by the Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma.
Cao W; Sun J
Anticancer Drugs; 2019 Mar; 30(3):218-224. PubMed ID: 30431444
[TBL] [Abstract][Full Text] [Related]
35. miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
Lv LY; Wang YZ; Zhang Q; Zang HR; Wang XJ
Cell Biochem Funct; 2015 Dec; 33(8):534-40. PubMed ID: 26559153
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
37. Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.
Ding Y; Pan Y; Liu S; Jiang F; Jiao J
Cancer Biol Ther; 2017 Jun; 18(6):414-424. PubMed ID: 28613134
[TBL] [Abstract][Full Text] [Related]
38. [The expression of MiR-148a in nasopharyngeal carcinoma and its effect on tumor cell biology functions in nasopharyngeal carcinoma].
Zhao JC; Shi Y; Zhang Y; Zhang X; Ma X; Jia ZH; Wu ZJ; Zhang JQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Aug; 30(15):1219-1223. PubMed ID: 29798333
[No Abstract] [Full Text] [Related]
39. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
[TBL] [Abstract][Full Text] [Related]
40. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
